Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 675

1.

Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels.

Kenny AM, Prestwood KM, Gruman CA, Marcello KM, Raisz LG.

J Gerontol A Biol Sci Med Sci. 2001 May;56(5):M266-72.

PMID:
11320105
3.

Effects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable testosterone levels.

Kenny AM, Bellantonio S, Gruman CA, Acosta RD, Prestwood KM.

J Gerontol A Biol Sci Med Sci. 2002 May;57(5):M321-5.

PMID:
11983727
4.

Determinants of bone density in healthy older men with low testosterone levels.

Kenny AM, Prestwood KM, Marcello KM, Raisz LG.

J Gerontol A Biol Sci Med Sci. 2000 Sep;55(9):M492-7.

PMID:
10995046
5.

Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy.

Howell SJ, Radford JA, Adams JE, Smets EM, Warburton R, Shalet SM.

Clin Endocrinol (Oxf). 2001 Sep;55(3):315-24.

PMID:
11589674
6.

Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.

Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ.

J Bone Miner Res. 2004 Aug;19(8):1221-30. Epub 2004 May 24.

9.

Sex steroids and bone turnover markers in men with symptomatic vertebral fractures.

Tuck SP, Scane AC, Fraser WD, Diver MJ, Eastell R, Francis RM.

Bone. 2008 Dec;43(6):999-1005. doi: 10.1016/j.bone.2008.08.123. Epub 2008 Sep 11.

PMID:
18817902
10.

Regional bone mineral density after resistive training in young and older men and women.

Ryan AS, Ivey FM, Hurlbut DE, Martel GF, Lemmer JT, Sorkin JD, Metter EJ, Fleg JL, Hurley BF.

Scand J Med Sci Sports. 2004 Feb;14(1):16-23.

PMID:
14723783
11.

Predictors of bone mass in healthy older men in the community.

Smerdely P, Seller M, Smith A, Day P, Diamond T.

Med J Aust. 2000 Aug 21;173(4):183-6.

PMID:
11008590
12.

Bone density, bone turnover, and hormone levels in men over age 75.

Kenny AM, Gallagher JC, Prestwood KM, Gruman CA, Raisz LG.

J Gerontol A Biol Sci Med Sci. 1998 Nov;53(6):M419-25.

PMID:
9823745
13.

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis.

Isidori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V, Isidori A, Lenzi A, Fabbri A.

Clin Endocrinol (Oxf). 2005 Sep;63(3):280-93. Review.

PMID:
16117815
14.

Effects of transdermal testosterone on lipids and vascular reactivity in older men with low bioavailable testosterone levels.

Kenny AM, Prestwood KM, Gruman CA, Fabregas G, Biskup B, Mansoor G.

J Gerontol A Biol Sci Med Sci. 2002 Jul;57(7):M460-5.

PMID:
12084809
15.

Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty.

Kenny AM, Kleppinger A, Annis K, Rathier M, Browner B, Judge JO, McGee D.

J Am Geriatr Soc. 2010 Jun;58(6):1134-43. doi: 10.1111/j.1532-5415.2010.02865.x.

16.

Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status.

Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P, Morley JE.

J Gerontol A Biol Sci Med Sci. 2003 Jul;58(7):618-25.

PMID:
12865477
17.

The impact of mild Leydig cell dysfunction following cytotoxic chemotherapy on bone mineral density (BMD) and body composition.

Howell SJ, Radford JA, Adams JE, Shalet SM.

Clin Endocrinol (Oxf). 2000 May;52(5):609-16.

PMID:
10792341
18.

Serum testosterone and its relation to bone mineral density and body composition in normal males.

Ongphiphadhanakul B, Rajatanavin R, Chailurkit L, Piaseu N, Teerarungsikul K, Sirisriro R, Komindr S, Puavilai G.

Clin Endocrinol (Oxf). 1995 Dec;43(6):727-33.

PMID:
8736276
19.

DHEA in elderly women and DHEA or testosterone in elderly men.

Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, Vittone JL, Klee GG, Basu A, Basu R, Cobelli C, Toffolo G, Dalla Man C, Tindall DJ, Melton LJ 3rd, Smith GE, Khosla S, Jensen MD.

N Engl J Med. 2006 Oct 19;355(16):1647-59.

20.

Increase of bioavailable testosterone is associated with gain in bone mineral density after cure of primary hyperparathyroidism in postmenopausal women.

Almqvist EG, Becker C, Bondeson AG, Bondeson L, Svensson J.

Clin Endocrinol (Oxf). 2006 Jan;64(1):58-62.

PMID:
16402929

Supplemental Content

Support Center